# Direct Measurement of Microstructure of Ingestive Behaviour After Initiation of GLP-1 Receptor Agonist Treatment at Maximum Dose (DIGRAT)

> **NCT07457424** · — · ACTIVE_NOT_RECRUITING · sponsor: **University College Dublin** · enrollment: 140 (estimated)

## Conditions studied

- Metabolic Disease
- Obesity & Overweight

## Interventions

- **DRUG:** semaglutide 1 mg weekly injection

## Key facts

- **NCT ID:** NCT07457424
- **Lead sponsor:** University College Dublin
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-02-17
- **Primary completion:** 2026-08-31
- **Final completion:** 2027-01-31
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2026-05-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07457424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07457424, "Direct Measurement of Microstructure of Ingestive Behaviour After Initiation of GLP-1 Receptor Agonist Treatment at Maximum Dose (DIGRAT)". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT07457424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*